Valuation: Beijing Science Sun Pharmaceutical Co., Ltd.

Market Cap 4.64B 687M 595M 555M 509M 958M 65.41B 973M 6.51B 2.56B 32.79B 2.58B 2.52B 108B P/E 2024
-50.1x
P/E 2025 353x
Enterprise Value 3.1B 459M 397M 371M 340M 639M 43.66B 650M 4.35B 1.71B 21.89B 1.72B 1.69B 72.35B EV / Sales 2024
4.33x
EV / Sales 2025 8.78x
Free-Float
42.82%
Yield 2024 *
-
Yield 2025 2.84%
1 day+5.94%
1 week+9.43%
Current month+9.43%
1 month+3.88%
3 months-10.67%
6 months-15.15%
Current year-8.98%
1 week 8.73
Extreme 8.73
9.65
1 month 8.35
Extreme 8.35
10.51
Current year 7.77
Extreme 7.77
12.9
1 year 7.77
Extreme 7.77
16.25
3 years 5.73
Extreme 5.73
17.49
5 years 5.73
Extreme 5.73
18.75
10 years 5.73
Extreme 5.73
28.08
Manager TitleAgeSince
Chief Executive Officer 62 2001-07-04
Director of Finance/CFO 45 2024-01-25
Director of Finance/CFO 57 2006-12-14
Director TitleAgeSince
Director/Board Member 48 2009-02-28
Chairman 62 2001-07-04
Director/Board Member 57 2005-09-30
Date Insider Type Main position Quantity % Market Cap.
1/20/26 Sell

Director

780,000 0.3078%
1/15/26 Sell

Director

2,301,800 0.9083%
1/14/26 Sell

Director

820,000 0.3236%
Change 5-day change 1-year change 3-year change Capi.($)
+5.94%+9.43%-33.77%-8.11% 687M
-0.52%+3.21%+85.02%+161.12% 1,057B
+0.88%+1.13%+51.13%+49.76% 625B
+0.89%-1.95%+23.73%+63.67% 435B
+0.71%+3.87%+47.45%+38.68% 363B
+0.64%-0.49%+35.39%+40.21% 296B
+0.39%-5.83%+8.64%+9.28% 249B
+1.51%+6.69%+44.34%+62.47% 222B
+3.92%-0.46%-1.21%-44.09% 209B
+1.80%+2.30%+20.79%+65.13% 165B
Average +1.78%+1.60%+28.15%+43.81% 362.15B
Weighted average by Cap. +1.12%+1.22%+48.32%+75.32%

Financials

2024 2025
Net sales 416M 61.71M 53.38M 49.85M 45.73M 86.01M 5.87B 87.38M 585M 230M 2.94B 232M 227M 9.73B 405M 59.97M 51.87M 48.44M 44.44M 83.58M 5.71B 84.91M 568M 223M 2.86B 225M 220M 9.46B
Net income -68.85M -10.2M -8.83M -8.24M -7.56M -14.22M -971M -14.45M -96.69M -37.95M -487M -38.31M -37.47M -1.61B 14.57M 2.16M 1.87M 1.74M 1.6M 3.01M 205M 3.06M 20.46M 8.03M 103M 8.11M 7.93M 340M
Net Debt -1.57B -233M -201M -188M -173M -325M -22.16B -330M -2.21B -866M -11.11B -875M -855M -36.73B -1.54B -229M -198M -185M -169M -318M -21.75B -324M -2.17B -850M -10.9B -858M -839M -36.04B
Logo Beijing Science Sun Pharmaceutical Co., Ltd.
Beijing Science Sun Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of injectables. The Company's products are biological and biochemical drugs, covering several drug use areas: cardiovascular and cerebrovascular diseases, immune diseases (anti-tumor) and nervous system diseases. The main products of immunomodulatory drugs are Saisheng Bozhi glycopeptide injection and Saisheng deoxyribonucleotide sodium injection. The main products of cardiovascular and cerebrovascular drugs are Saibai fibrinolytic enzyme injection, myo-aminopeptide injection and myo-aminopeptide injection. The main product of nervous system drugs is Saidian monosialotetrahexosylganglioside sodium injection (GM-1). The Company mainly conducts its businesses in the domestic market.
Employees
489
Date Price Change Volume
26-08-07 CN¥9.630 +5.94% 14,322,730
26-08-06 CN¥9.090 -0.66% 5,094,300
26-08-05 CN¥9.150 +0.11% 5,462,205
26-08-04 CN¥9.140 +2.70% 7,066,002
26-08-03 CN¥8.900 +1.14% 4,687,800
  1. Stock Market
  2. Stocks
  3. 300485 Stock